Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Free Cash Flow (2016 - 2025)

Nutex Health's Free Cash Flow history spans 16 years, with the latest figure at $70.4 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 20720.83% year-over-year to $70.4 million; the TTM value through Dec 2025 reached $248.1 million, up 1026.29%, while the annual FY2025 figure was $248.1 million, 1090.11% up from the prior year.
  • Free Cash Flow for Q4 2025 was $70.4 million at Nutex Health, down from $99.5 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $99.5 million in Q3 2025 and bottomed at -$13.2 million in Q3 2022.
  • The 5-year median for Free Cash Flow is $11.0 million (2022), against an average of $21.7 million.
  • The largest annual shift saw Free Cash Flow crashed 163.54% in 2022 before it surged 20720.83% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at $34.7 million in 2021, then plummeted by 64.31% to $12.4 million in 2022, then crashed by 114.34% to -$1.8 million in 2023, then soared by 80.78% to -$341349.0 in 2024, then soared by 20720.83% to $70.4 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Free Cash Flow are $70.4 million (Q4 2025), $99.5 million (Q3 2025), and $27.3 million (Q2 2025).